Bliss Gvs Pharma Ltd Share Price History
Bliss GVS Pharma Ltd
NSE : 02 Feb, 2026
170.770.3 (0.2%)
Prev Close
170.5
Open Price
168.7
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1075333
Today's High / Low
173.7 / 166.4
52 WK High / Low
195.8 / 108.1
Market Price of Bliss GVS Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 10.92 |
| YoY Gr. | - |
| Net Profit (Cr.) | 113 |
| BVPS | 47.18 |
Key Financial Parameters
| Parameter | 2016 |
|---|---|
| Return on Capital Emp. % | 31.96 |
| Op. Profit Mgn % | 32.77 |
| Net Profit Mgn % | 18.23 |
| Debt to Equity % | 0.39 |
Latest Shareholding
Promoters Holdings Over Time
About Bliss GVS Pharma Ltd
- Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
- The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
- The Company has its manufacturing facility at Palghar which is WHO GMP approved.
- The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards. The company commenced its business in 1985.
- In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR).
Popular Search
FAQs for Bliss GVS Pharma Ltd Share Price History
What are the key events that typically impact Bliss GVS Pharma Ltd's share price history?
Key events that impact Bliss GVS Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Bliss GVS Pharma Ltd's share price history?
Stock splits reduce the nominal price of Bliss GVS Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Bliss GVS Pharma Ltd?
Dividends can influence Bliss GVS Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Bliss GVS Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Bliss GVS Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Bliss GVS Pharma Ltd’s share price history?
To understand Bliss GVS Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
